Skip to main content
Equibles
CERS logo

CERS · Cerus Corp · Earnings Call Transcripts & Audio

Track CERS — free

Use CERS with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research CERS.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$2.38 -0.09 (-3.64%) At close · Sep 30
Russell 2000 member Rebalance outlook locked
Market Cap
$488.70M
Shares
201.52M
Volume · Sep 30 1.93M Avg daily vol (3M) 2.29M

Cerus Corp Earnings Call Transcripts

Quarterly earnings calls for Cerus Corp (CERS), with available speaker-labelled transcripts, captured audio replays, call highlights, 8-K earnings releases and periodic filings. Investor days and conferences appear here too.

Pull transcripts and briefs through the earnings call transcript API or MCP →

Revenue & result across quarters

Revenue Net income YoY up YoY down artefacts
· $43.24M −$7.72M '25 Q1 25-05-01 · $52.45M −$5.71M '25 Q2 25-08-05 ▲24.1% $53.66M −$1.64M '26 Q1 26-04-30 LATEST ▲9.5% $57.44M −$2.94M '26 Q2 26-07-30
Earnings call
FY26 · Q2
2026-07-30
Cerus Corp (CERS) Q2 2026 Earnings Call Transcript
Confident tone U.S. ISB franchise growth EMEA / international expansion ISD / fibrinogen adoption
Revenue
$57.44M
▲ 9.5% YoY
Diluted EPS
$-0.01
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY26 · Q1
2026-04-30
Cerus Corp (CERS) Q1 2026 Earnings Call Transcript
Confident tone Product revenue growth and raised guidance Innovation pipeline: IND200, IND100 PMA, red blood cells EMEA performance and France/EFS contract
Revenue
$53.66M
▲ 24.1% YoY
Diluted EPS
$-0.01
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q4
2026-03-02
Cerus Corp (CERS) Q4 2025 Earnings Call Transcript
Confident tone U.S. platelet franchise and BCA agreement IFC (Intercept Fibrinogen Complex) demand EMEA growth and Germany opportunity
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY25 · Q3
2025-11-06
Cerus Corp (CERS) Q3 2025 Earnings Call Transcript
Confident tone IFC (red blood cells) business and kit model transition Path to positive non-GAAP adjusted EBITDA International / EMEA expansion
Diluted EPS
$0.00
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q2
2025-08-05
Cerus Corp (CERS) Q2 2025 Earnings Call Transcript
Confident tone IFC (Fibrinogen Complex) Growth INT200 Illuminator Launch Red Blood Cell CE Mark Submission (Europe)
Revenue
$52.45M
Diluted EPS
$-0.03
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q1
2025-05-01
Cerus Corp (CERS) Q1 2025 Earnings Call Transcript
Confident tone US platelet and IFC franchise growth INT200 next-generation illumination device INTERCEPT red blood cell CE Mark submission
Revenue
$43.24M
Diluted EPS
$-0.04
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q4
2025-02-20
Cerus Corp (CERS) Q4 2024 Earnings Call Transcript
Confident tone 2025 Revenue Guidance & Outlook International Geographic Expansion U.S. IFC (Fibrinogen Complex) Franchise
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY24 · Q3
2024-10-30
Cerus Corp (CERS) Q3 2024 Earnings Call Transcript
Confident tone INTERCEPT Fibrinogen Complex (IFC) Operating Cash Flow and EBITDA Leverage BARDA Contract and RBC Program
Diluted EPS
$-0.02
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q2
2024-08-01
Cerus Corp (CERS) Q2 2024 Earnings Call Transcript
Confident tone IFC (Interluekin/synthetic) franchise growth Adjusted EBITDA breakeven target International expansion (Canada, EMEA, Middle East, China)
Diluted EPS
$-0.03
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q1
2024-05-02
Cerus Corp (CERS) Q1 2024 Earnings Call Transcript
Positive tone INTERCEPT Fibrinogen Complex (IFC) Cash Flow & Working Capital ReCePI Phase III RBC Trial
Diluted EPS
$-0.05
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q4
2024-03-05
Cerus Corp (CERS) Q4 2023 Earnings Call Transcript
Confident tone INTERCEPT Fibrinogen Complex (IFC) U.S. launch INTERCEPT platelet franchise growth First positive non-GAAP adjusted EBITDA
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY23 · Q3
2023-11-02
Cerus Corp (CERS) Q3 2023 Earnings Call Transcript
Diluted EPS
$-0.04
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q2
2023-08-02
Cerus Corp (CERS) Q2 2023 Earnings Call Transcript
Diluted EPS
$-0.07
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q1
2023-05-04
Cerus Corp (CERS) Q1 2023 Earnings Call Transcript
Diluted EPS
$-0.09
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q4
2023-02-28
Cerus Corp (CERS) Q4 2022 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY22 · Q3
2022-11-03
Cerus Corp (CERS) Q3 2022 Earnings Call Transcript
Diluted EPS
$-0.05
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q2
2022-08-04
Cerus Corp (CERS) Q2 2022 Earnings Call Transcript
Diluted EPS
$-0.05
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q1
2022-05-05
Cerus Corp (CERS) Q1 2022 Earnings Call Transcript
Diluted EPS
$-0.07
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q4
2022-02-22
Cerus Corp (CERS) Q4 2021 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY21 · Q3
2021-11-02
Cerus Corp (CERS) Q3 2021 Earnings Call Transcript
Diluted EPS
$-0.07
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q2
2021-08-03
Cerus Corp (CERS) Q2 2021 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q1
2021-05-04
Cerus Corp (CERS) Q1 2021 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q3
2020-10-29
Cerus Corp (CERS) Q3 2020 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q2
2020-08-04
Cerus Corp (CERS) Q2 2020 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q1
2020-05-05
Cerus Corp (CERS) Q1 2020 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-Q
Showing 1–25 of 25 earnings calls
Key facts CIK 1020214 CUSIP 157085101 13F (30d) 4 filings 4 filers Visit website Investor relations